Sinopharm Group Co. Ltd.
SHTDFOTCHealthcare● Active
$2.30
+$0.01(+0.44%)
Market Cap$7.2B
P/E Ratio—
52W High$2.7
52W Low$2.11
Sinopharm Group Co. Ltd. (SHTDF) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SHTDF · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $61.59B | $54.31B | $63.81B | $55.22B | $43.54B |
| Net Receivables | $206.76B | $206.72B | $185.79B | $171.20B | $172.58B |
| Inventory | $63.37B | $62.35B | $60.03B | $60.93B | $51.50B |
| Total Current Assets | $346.97B | $347.45B | $336.84B | $319.41B | $290.92B |
| PP&E Net | $18.24B | $19.63B | $19.90B | $17.79B | $17.60B |
| Goodwill | $5.78B | $6.25B | $7.19B | $7.16B | $7.20B |
| Intangible Assets | $4.36B | $4.72B | $2.83B | $4.87B | $5.00B |
| Total Assets | $390.56B | $392.83B | $383.39B | $364.78B | $335.41B |
| Liabilities | |||||
| Short-Term Debt | $63.32B | $62.73B | $54.73B | $53.00B | $55.15B |
| Accounts Payable | $112.68B | $156.87B | $154.75B | $144.62B | $132.87B |
| Total Current Liabilities | $246.85B | $250.38B | $241.49B | $234.96B | $219.31B |
| Long-Term Debt | $3.65B | $8.64B | $13.83B | $11.75B | $8.42B |
| Total Liabilities | $256.33B | $266.14B | $263.08B | $254.71B | $235.76B |
| Stockholders Equity | |||||
| Retained Earnings | $58.81B | $53.74B | $49.41B | $42.87B | $38.52B |
| Total Stockholders Equity | $84.00B | $78.88B | $74.58B | $68.07B | $61.89B |
| Total Liab & Equity(computed) | $340.33B | $345.03B | $337.66B | $322.77B | $297.64B |
| Debt Summary | |||||
| Total Debt | $108.64B | $76.39B | $73.78B | $69.59B | $68.37B |
| Net Debt | $47.04B | $22.07B | $9.97B | $14.37B | $24.84B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CNY · B
Explore more Sinopharm Group Co. Ltd. data
About Sinopharm Group Co. Ltd. (SHTDF) Balance Sheet
Sinopharm Group Co. Ltd. (SHTDF) balance sheet shows total assets of $390.56B with cash of $61.59B. Total liabilities are $256.33B, total debt $108.64B, and stockholders equity $84.00B.
Frequently asked questions
SHTDF · 4 questionsSinopharm Group Co. Ltd. has total debt of $108.64B with net debt of $47.04B.
SHTDF total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10